PRIMARY STUDY

In Vitro Evaluation of the Activity of Terpenes and Cannabidiol against Human Coronavirus E229

Key Findings:  Secondary cannabis compounds such as terpenes have been shown to have significant antiviral potential and low toxicity, making them good candidates for use as antiviral agents with minimal side effects. The combination of NT-VRL-1 (a proprietary terpene formulation) with CBD may have an antiviral effect against human coronaviruses.

Type of Study:  Laboratory Study

Study Result:  Positive

Study Location(s):  Israel

Year of Pub:  2021


Cannabinoids Studied:  Cannabidiol (CBD), Cannabinoid (unspecified)

Phytocannabinoid Source:  Unspecified

Terpenes Studied:  ß-Caryophyllene, Eucalyptol

Route of Administration:  In vitro



Link to study